InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Khurram Jamil
6 Jan 2026
Chief Medical Officer
Sold on a plan
21,446
$3.65
$78.20K
Jack W Callicutt
6 Jan 2026
Chief Financial Officer
Sold on a plan
20,354
$3.67
$74.70K
Joel Lewis
6 Jan 2026
President and CEO
Sold on a plan
37,698
$3.58
$134.85K
Khurram Jamil
5 Jan 2026
Chief Medical Officer
Sold on a plan
25,499
$3.90
$99.41K
Jack W Callicutt
5 Jan 2026
Chief Financial Officer
Sold on a plan
25,732
$3.90
$100.30K
Joel Lewis
5 Jan 2026
President and CEO
Sold on a plan
27,731
$3.91
$108.34K
Show all 59 transactions →

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 43
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 35,181,445
History held since 9 Feb 2007